Online:
Visits:
Stories:
Profile image
Story Views

Now:
Last Hour:
Last 24 Hours:
Total:

Webinar Presentation on ”In situ Hybridization Market – Global Forecast to 2021” to be held on 10 Feb,2017.

Tuesday, February 7, 2017 13:03
% of readers think this story is Fact. Add your two cents.

(Before It's News)

The Healthcare practice at MarketsandMarkets is pleased to announce its Webinar on the In situ Hybridization Market by Technique (FISH, CISH), Application (Cancer Diagnosis, Neuroscience, Cytology, Infectious Disease), & End User (Molecular Diagnostic Laboratories, Academic And Research Institutions) – Global Forecast to 2021″, The event title “In Situ Hybridization: A Promising Adjunct to Immunohistochemistry” will be organized on February 10, 2017 from 09:00 pm to 09:30 pm. Join our experts as they speak about in situ hybridization market and its future prospects.

Webinar Signup @ http://www.marketsandmarkets.com/Webinar/in-situ-hybridization-market_212028829.asp

One of the major challenges faced by the healthcare industry is the growing burden of cancer worldwide. Cancer has profound social and economic consequences for people globally, and in situ hybridization has emerged as a powerful molecular tool for cancer diagnosis and treatment. The technique uses a labeled complementary DNA or RNA strand to localize a specific DNA or RNA sequence on a chromosome or section of tissue (in situ) fixed on a slide. Increasing diagnosis and growing prevalence of cancer, technological advancements in therapeutics, and increasing government initiatives globally are some of the pivotal factors triggering the growth of the market.

Specific Insights:

  1. How has the in situ hybridization technique evolved?
  2. What are the major market trends?
    • Technological advancements
    • Regional analysis
  3. What are the roadblocks to adoption of this technique?
  4. What are the growth strategies adopted by players to gain a competitive edge in this market?

List of Companies

  1. Abbott Laboratories, Inc.
  2. F.Hoffmann-La Roche Ltd.
  3. Thermofisher Scientific, Inc.
  4. Merck KGaA
  5. Agilent Technologies, Inc.
  6. Perkin Elmer, Inc.
  7. Danaher Corporation / Leica Biosystems Nussloch GmbH
  8. Exiqon A/S
  9. Biogenex Laboratories, Inc.
  10. Advanced Cell Diagnostics, Inc.
  11. Bio Sb, Inc.

About MarketsandMarkets

MarketsandMarkets is the largest market research firm worldwide in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to a multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the “Growth Engagement Model – GEM”. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write “Attack, avoid and defend” strategies, identify sources of incremental revenues for both the company and its competitors.

Note: An email containing the Login Details and Time of the Webinar will be sent to you soon after your registration.

The Healthcare practice at MarketsandMarkets is pleased to announce its Webinar on the ” by Technique (FISH, CISH), Application (Cancer Diagnosis, Neuroscience, Cytology, Infectious Disease), & End User (Molecular Diagnostic Laboratories, Academic And Research Institutions) – Global Forecast to 2021″, The event title “In Situ Hybridization: A Promising Adjunct to Immunohistochemistry” will be organized on February 10, 2017 from 09:00 pm to 09:30 pm. Join our experts as they speak about in situ hybridization market and its future prospects.

Webinar Signup @ http://www.marketsandmarkets.com/Webinar/in-situ-hybridization-market_212028829.asp

One of the major challenges faced by the healthcare industry is the growing burden of cancer worldwide. Cancer has profound social and economic consequences for people globally, and in situ hybridization has emerged as a powerful molecular tool for cancer diagnosis and treatment. The technique uses a labeled complementary DNA or RNA strand to localize a specific DNA or RNA sequence on a chromosome or section of tissue (in situ) fixed on a slide. Increasing diagnosis and growing prevalence of cancer, technological advancements in therapeutics, and increasing government initiatives globally are some of the pivotal factors triggering the growth of the market.

Specific Insights:

  1. How has the in situ hybridization technique evolved?
  2. What are the major market trends?
    • Technological advancements
    • Regional analysis
  3. What are the roadblocks to adoption of this technique?
  4. What are the growth strategies adopted by players to gain a competitive edge in this market?

List of Companies

  1. Abbott Laboratories, Inc.
  2. F.Hoffmann-La Roche Ltd.
  3. Thermofisher Scientific, Inc.
  4. Merck KGaA
  5. Agilent Technologies, Inc.
  6. Perkin Elmer, Inc.
  7. Danaher Corporation / Leica Biosystems Nussloch GmbH
  8. Exiqon A/S
  9. Biogenex Laboratories, Inc.
  10. Advanced Cell Diagnostics, Inc.
  11. Bio Sb, Inc.

About MarketsandMarkets

MarketsandMarkets is the largest market research firm worldwide in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to a multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the “Growth Engagement Model – GEM”. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write “Attack, avoid and defend” strategies, identify sources of incremental revenues for both the company and its competitors.

 

Note: An email containing the Login Details and Time of the Webinar will be sent to you soon after your registration.

 

Report abuse

Comments

Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

Top Stories
Recent Stories

Register

Newsletter

Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.